Atlas Venture Advisors, Inc. - Q2 2022 holdings

$317 Million is the total value of Atlas Venture Advisors, Inc.'s 7 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 28.6% .

 Value Shares↓ Weighting
IAS  INTEGRAL AD SCIENCE HLDNG CO$225,637,000
-28.0%
22,722,7710.0%71.25%
+5.5%
NewDRAFTKINGS INC$76,504,0006,555,608
+100.0%
24.16%
ROKU  ROKU INC$4,740,000
-34.4%
57,7070.0%1.50%
-3.9%
FSTX  F-STAR THERAPEUTICS INC$3,599,000
+76.3%
574,9960.0%1.14%
+158.2%
SNAP  SNAP INCcl a$3,224,000
-63.5%
245,5590.0%1.02%
-46.5%
VRDN  VIRIDIAN THERAPEUTICS INC$2,424,000
-37.4%
209,5050.0%0.76%
-8.3%
LRMR  LARIMAR THERAPEUTICS INC$573,000
-51.6%
292,1840.0%0.18%
-29.0%
DKNG ExitDRAFTKINGS INC$0-6,555,608
-100.0%
-27.49%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SNAP INC20Q3 20236.1%
ROKU INC16Q3 202311.7%
LARIMAR THERAPEUTICS INC14Q3 20231.4%
TRANSLATE BIO INC11Q2 202152.9%
INTEGRAL AD SCIENCE HLDNG CO10Q3 202371.2%
BICYCLE THERAPEUTICS PLC10Q3 202125.2%
VIRIDIAN THERAPEUTICS INC10Q1 20232.1%
F-STAR THERAPEUTICS INC9Q4 20221.3%
DRAFTKINGS INC8Q1 202282.5%
MIRAGEN THERAPEUTICS INC8Q3 20205.0%

View Atlas Venture Advisors, Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-02
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR2023-05-08
13F-HR2023-01-31
13F-HR2022-11-10
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-01-27
13F-HR2021-11-04

View Atlas Venture Advisors, Inc.'s complete filings history.

Compare quarters

Export Atlas Venture Advisors, Inc.'s holdings